These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 9869224)
41. Concurrent chemotherapy and adjuvant extended field irradiation after radical surgery for cervical cancer patients with lymph node metastases. Cheng X; Cai SM; Li ZT; Wu XH; Ding YQ; Wang XE; Zang RY Int J Gynecol Cancer; 2008; 18(4):779-84. PubMed ID: 17944922 [TBL] [Abstract][Full Text] [Related]
42. Chemoradiation in cervical cancer with cisplatin and high-dose rate brachytherapy combined with external beam radiotherapy. Results of a phase-II study. Strauss HG; Kuhnt T; Laban C; Puschmann D; Pigorsch S; Dunst J; Koelbl H; Haensgen G Strahlenther Onkol; 2002 Jul; 178(7):378-85. PubMed ID: 12163992 [TBL] [Abstract][Full Text] [Related]
43. Enhancement of local control in locally advanced node-positive nasopharyngeal carcinoma by adjunctive chemotherapy. Teo PM; Chan AT; Lee WY; Leung TW; Johnson PJ Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):261-71. PubMed ID: 10030248 [TBL] [Abstract][Full Text] [Related]
44. Low-dose-rate californium-252 neutron intracavitary afterloading radiotherapy combined with conformal radiotherapy for treatment of cervical cancer. Zhang M; Xu HD; Pan SD; Lin S; Yue JH; Liu JR Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):966-71. PubMed ID: 22138462 [TBL] [Abstract][Full Text] [Related]
45. Induction chemotherapy followed by radiotherapy versus radiotherapy alone in patients with advanced nasopharyngeal carcinoma: results of a matched cohort study. Geara FB; Glisson BS; Sanguineti G; Tucker SL; Garden AS; Ang KK; Lippman SM; Clayman GL; Goepfert H; Peters LJ; Hong WK Cancer; 1997 Apr; 79(7):1279-86. PubMed ID: 9083147 [TBL] [Abstract][Full Text] [Related]
46. Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma. Hiura M; Nogawa T; Matsumoto T; Yokoyama T; Shiroyama Y; Wroblewski J Int J Gynecol Cancer; 2010 Aug; 20(6):1000-5. PubMed ID: 20683408 [TBL] [Abstract][Full Text] [Related]
47. [Simultaneous radiotherapy and chemotherapy in the treatment of advanced cancer of the cervix uteri]. Resbeut M; Noirclerc M; Viens P; d'Ercole C; Houvenaeghel G; Boubli L; Gamerre M; Delpéro JR Bull Cancer; 1993 Nov; 80(11):984-93. PubMed ID: 8081036 [TBL] [Abstract][Full Text] [Related]
48. [Pelvic radiation with concurrent chemotherapy compared with pelvi and para-aortic radiation for high-risk cervical cancer. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. Cisplatin, radiation, and adjuvant hysterectomy for bulky stage Ib cervical carcinoma]. Nöel G; Mazeron JJ Cancer Radiother; 1999; 3(4):345-7. PubMed ID: 10515699 [No Abstract] [Full Text] [Related]
49. Mitomycin-C/5-FU and radiation therapy for locally advanced uterine cervical cancer. Nguyen PD; John B; Munoz AK; Yazigi R; Graham M; Franklin P Gynecol Oncol; 1991 Dec; 43(3):220-5. PubMed ID: 1752491 [TBL] [Abstract][Full Text] [Related]
51. Hyperfractionated radiation therapy and concurrent 5-fluorouracil, cisplatin and mitomycin-C in head and neck carcinoma. A pilot study. Abitbol AA; Schwade JG; Lewin AA; Sridhar K; Brandon AH; Markoe AM; Casiano RR; Houdek PV; Serago C; Miller DJ Am J Clin Oncol; 1992 Jun; 15(3):250-5. PubMed ID: 1590280 [TBL] [Abstract][Full Text] [Related]
52. Irradiation with or without misonidazole for patients with stages IIIB and IVA carcinoma of the cervix: final results of RTOG 80-05. Radiation Therapy Oncology Group. Grigsby PW; Winter K; Wasserman TH; Marcial V; Rotman M; Cooper J; Keys H; Asbell SO; Phillips TL Int J Radiat Oncol Biol Phys; 1999 Jun; 44(3):513-7. PubMed ID: 10348279 [TBL] [Abstract][Full Text] [Related]
54. Split-field helical tomotherapy with or without chemotherapy for definitive treatment of cervical cancer. Chang AJ; Richardson S; Grigsby PW; Schwarz JK Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):263-9. PubMed ID: 21167656 [TBL] [Abstract][Full Text] [Related]
55. Final results of a phase II chemoradiation protocol for locally advanced cervical cancer: RTOG 85-15. John M; Flam M; Caplan R; Rotman M; Quivey J; Steinfeld A; Russell A Gynecol Oncol; 1996 May; 61(2):221-6. PubMed ID: 8626137 [TBL] [Abstract][Full Text] [Related]
56. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. Rose PG; Bundy BN; Watkins EB; Thigpen JT; Deppe G; Maiman MA; Clarke-Pearson DL; Insalaco S N Engl J Med; 1999 Apr; 340(15):1144-53. PubMed ID: 10202165 [TBL] [Abstract][Full Text] [Related]
58. A phase II trial of less than 7 weeks of concomitant cisplatin-paclitaxel chemoradiation in locally advanced cervical cancer. Martínez-Monge R; Gaztañaga M; Aramendía JM; Cambeiro M; Arbea L; Espinós J; Aristu JJ; Jurado M Int J Gynecol Cancer; 2010 Jan; 20(1):133-40. PubMed ID: 20130514 [TBL] [Abstract][Full Text] [Related]
59. Extended field chemoradiation for cervical cancer patients with histologically proven para-aortic lymph node metastases after laparaoscopic lymphadenectomy. Marnitz S; Schram J; Budach V; Sackerer I; Vercellino GF; Sehouli J; Köhler C Strahlenther Onkol; 2015 May; 191(5):421-8. PubMed ID: 25413986 [TBL] [Abstract][Full Text] [Related]